Richard Cutcher

Short: Meet the UK’s captive regulators

Richard is joined by the insurance regulators currently consulting on and implementing the United Kingdom's first captive insurance regulatory regime.

Exclusive: Aon appoints new Guernsey domicile leader

Aon has appointed Paul Morgan as its domicile leader for Guernsey as it invests in new talent and continues its reognisation under CEO and global captives leader Ciarán Healy.

Allianz tap Stephen Morton to succeed Brian McNamara

Experienced fronting operator Stephen Morton will join Allianz Commercial as its new global head of captive fronting and captive solutions.

Short: Captive Structured Solutions

Joe Filby, at AXA XL, and Lockton's James Donald, discuss alternative risk transfer and structured solutions.

UFP Industries captive get Excellent rating affirmed

AM Best has affirmed the financial strength rating of ‘A’ (Excellent) and the long-term issuer credit rating of “a” (Excellent) of Ardellis Insurance Ltd in Bermuda.

BP’s Guernsey captive gets rating affirmed

Jupiter Insurance Limited, the 33-year-old captive owned by BP plc, has had its ratings affirmed by AM Best.

BP dissolves Vermont captive

BP plc has dissolved its Vermont-domiciled captive and surrendered its licence.

Aon appoints Charles Winter as Hub Leader for UK, Guernsey, IoM

Charles Winter has been appointed Aon’s Hub Leader for UK, Guernsey and Isle of Man Captive Management.

Latest Podcasts

Short: Meet the UK’s captive regulators

Richard is joined by the insurance regulators currently consulting on and implementing the United Kingdom's first captive insurance regulatory regime.

Short: Captive Structured Solutions

Joe Filby, at AXA XL, and Lockton's James Donald, discuss alternative risk transfer and structured solutions.

Short: From Obesity Drug to Risk Strategy – Why Captives Need to Rethink GLP-1s

In this GCP Short, produced in partnership with ⁠MAXIS Global Benefits Network⁠, we explore findings from the network's latest whitepaper on GLP-1s, often known as weight-loss drugs.

Trending